References
- BIPM - JCTLM. Frequently asked questions. June 2016. Available from: http://www.bipm.org/en/committees/jc/jctlm/jctlm-faq.html.
- Miller WG, Myers GL, Gantzer ML, Kahn SE, Schonbrunner ER, Thienpont LM, Bunk DM, Christenson RH, Eckfeldt JH, Lo SF, Nubling CM, Sturgeon CM. Roadmap for harmonization of clinical laboratory measurement procedures. Clin Chem 2011;57:1108–17.
- Sturgeon CM. External quality assessment of hormone determinations. Best Pract Res Clin Endocrinol Metab 2013;27:803–22.
- Healy MJ. Outliers in clinical chemistry quality-control schemes. Clin Chem 1979;25:675–7.
- UK NEQAS [Edinburgh] Participants’ Handbook. 2015 June 2016. Available from: www.edqas.org.
- Miller WG, Jones GR, Horowitz GL, Weykamp C. Proficiency testing/external quality assessment: current challenges and future directions. Clin Chem 2011;57:1670–80.
- Sturgeon CM. Common decision limits – the need for harmonised immunoassays. Clin Chim Acta 2014;432:122–6.
- Miller WG, Myers GL, Rej R. Why commutability matters. Clin Chem 2006;52:553–4.
- Egner W, White P, Patel D, Packer S, Jewess P, Murray D. Assessment of preparations of the mucin tumor marker antigens on different immunoassay platforms. AACC Meeting Abstract; 2009.
- Song PP, Xia JF, Inagaki Y, Hasegawa K, Sakamoto Y, Kokudo N, Tang W. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. World J Gastroenterol 2016;22:262–74.
- Boegemann M, Stephan C, Cammann H, Vincendeau S, Houlgatte A, Jung K, Blanchet JS, Semjonow A. The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the prostate health index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged </=65 years. BJU Int 2016;117:72–9.
- Bristow A, Berger P, Bidart JM, Birken S, Norman R, Stenman UH, Sturgeon C. Establishment, value assignment, and characterization of new WHO reference reagents for six molecular forms of human chorionic gonadotropin. Clin Chem 2005;51:177–82.
- Sturgeon CM, Berger P, Bidart JM, Birken S, Burns C, Norman RJ, Stenman UH. Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin. Clin Chem 2009;55:1484–91.
- Rye PD, Nustad K, Stigbrand T. Tumor marker workshops. Tumour Biol 2003;24:165–71.
- Lapthorn AJ, Harris DC, Littlejohn A, Lustbader JW, Canfield RE, Machin KJ, Morgan FJ, Isaacs NW. Crystal structure of human chorionic gonadotropin. Nature 1994;369:455–61.
- Berger P, Sturgeon C, Bidart JM, Paus E, Gerth R, Niang M, Bristow A, Birken S, Stenman UH. The ISOBM TD-7 Workshop on hCG and related molecules. Towards user-oriented standardization of pregnancy and tumor diagnosis: assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives. Tumour Biol 2002;23:1–38.
- Berger P, Paus E, Hemken PM, Sturgeon C, Stewart WW, Skinner JP, Harwick LC, Saldana SC, Ramsay CS, Rupprecht KR, Olsen KH, Bidart JM, Stenman UH. Candidate epitopes for measurement of hCG and related molecules: the second ISOBM TD-7 workshop. Tumour Biol 2013;34:4033–57.
- Berger P, Lapthorn A. Standardization of epitopes for human chorionic gonadotropin (hCG) Immunoassays. Curr Med Chem 2016;23. [E-pub ahead of print]. doi: 10.2174/0929867323666160530145503.